Advertisement
Canada markets closed
  • S&P/TSX

    21,656.05
    +13.18 (+0.06%)
     
  • S&P 500

    5,022.21
    -29.20 (-0.58%)
     
  • DOW

    37,753.31
    -45.66 (-0.12%)
     
  • CAD/USD

    0.7268
    +0.0004 (+0.06%)
     
  • CRUDE OIL

    82.75
    +0.06 (+0.07%)
     
  • Bitcoin CAD

    85,111.44
    -3,393.55 (-3.83%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,381.80
    -6.60 (-0.28%)
     
  • RUSSELL 2000

    1,947.95
    -19.53 (-0.99%)
     
  • 10-Yr Bond

    4.5850
    -0.0740 (-1.59%)
     
  • NASDAQ futures

    17,702.75
    +44.25 (+0.25%)
     
  • VOLATILITY

    18.21
    -0.19 (-1.03%)
     
  • FTSE

    7,847.99
    +27.63 (+0.35%)
     
  • NIKKEI 225

    37,907.65
    -54.15 (-0.14%)
     
  • CAD/EUR

    0.6806
    +0.0004 (+0.06%)
     

The Real Reason Pfizer Wanted Allergan Becomes Abundantly Clear

Pfizer's decision to walk away from Allergan tells investors that its interest was always tied more to the tax savings than it was to Allergan's products and pipeline.

This podcast was recorded on Apr. 6, 2016.